National Institutes of Health
9000 Rockville Pike
1981 articles about National Institutes of Health
CHOP and Penn Researchers Receive $50 Million NIH Grant to Study Impact of Environmental Factors on Pregnancy and Children's Health
A multidisciplinary group of researchers from Children's Hospital of Philadelphia and Penn Medicine have received a $50 million grant from the National Institutes of Health to study the impact of environmental influences on pregnancy and children's health.
Omniose, a company developing polysaccharide conjugate vaccines against serious bacterial threats, announced a grant award up to $3.0 million for the development of a Group B Streptococcus vaccine from the National Institute of Allergy and Infectious Diseases of the U.S. National Institutes of Health.
Beactica Therapeutics announces collaboration with the National Center for Advancing Translational Sciences
Beactica Therapeutics AB, the Swedish precision oncology company, announced that it has entered into a research collaboration agreement with the National Center for Advancing Translational Sciences, one of 27 institutes and centers at the U.S. National Institutes of Health.
South Rampart Pharma, Inc. announced that it has been awarded The Commercialization Readiness Pilot Program grant by the NIH, NINDS for its application entitled 'Novel non-narcotic analgesic for acute and chronic pain.'
Scene Health & The Research Institute at Nationwide Children’s Hospital Secure $1.9M in NIH Funding to Pursue Improvements in Sickle Cell Disease Care and Outcomes
Sickle cell disease hurts, and the debilitating pain can send children to the hospital multiple times a year.
Perosphere Technologies has announced the receipt of two prestigious federal grants: a Direct Phase II Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, and a subaward through an Atlanta Center for Microsystems Engineered Point-of-Care Technologies Center Grant, funded by the National Institute of Biomedical Imaging and Bioengineering.
Burst Diagnostics, a pioneering force in rapid, point-of-care diagnostic solutions, proudly announces the appointments of Drs. Larry Jia and Mary Gunn to its Board of Directors.
Subtle Medical was awarded a federal SBIR grant from the National Institutes of Health to expand their artificial intelligence -powered software solution, SubtleSYNTH™, which uses deep learning to synthesize Magnetic Resonance Imaging contrasts from already-acquired contrasts.
Montefiore Einstein Comprehensive Cancer Center Awarded Comprehensive Designation from the National Cancer Institute
The newly renamed Montefiore Einstein Comprehensive Cancer Center has been awarded comprehensive designation by the National Cancer Institute of the National Institutes of Health, the ultimate standard achieved by only 55 other NCI cancer centers in the U.S. Through NCI's peer-review process, MECCC was nationally recognized for its paradigm-shifting, practice-changing, policy-impacting cancer-focused science.
Spinogenix Awarded $3 Million NIH Grant to Support Continued Development of SPG302, the First Synaptic Regenerative Therapeutic for Alzheimer’s Disease
Spinogenix, Inc., a clinical-stage biopharmaceutical company developing novel small molecule drugs for neurological conditions, announced a second grant award by the National Institute of Health.
Co-Diagnostics, Inc. announced that it has been awarded $1.2 million in funding from the National Institutes of Health as part of the Rapid Acceleration of Diagnostics Tech program for completion of its upcoming upper respiratory panel on the Company's Co-Dx PCR Home™ testing platform.
Zymedi announced their collaboration with the National Heart, Lung, and Blood Institute through a CTA CRADA to develop ZMA001 mAb, a potential treatment for Pulmonary Arterial Hypertension (PAH), a rare, female predominant disease
Zymedi announced the signing of a clinical Cooperative Research and Development Agreement with the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to develop ZMA001 for the treatment of pulmonary arterial hypertension.
New research from the National Institutes of Health found that blood glucose levels obtained at childhood examinations predicted future diabetes related complications such as kidney disease and eye disease.
The Bespoke Gene Therapy Consortium intends to bring AAV-based gene therapies to patients whose diseases are often ignored by commercial interests.
Foresight Diagnostics Announces Study Demonstrating Prognostic Utility of PhasED-Seq™ for MRD Assessment after Frontline DLBCL Treatment at the 17th International Conference on Malignant Lymphoma
Foresight Diagnostics announced that Mark Roschewski, MD, of the National Cancer Institute, part of the National Institutes of Health, will present pooled data from six recent clinical studies on June 14th at the 17th International Conference on Malignant Lymphoma in Lugano, Switzerland.
NIH Awards $14.4 Million to NDRI to Collaborate on the Somatic Mosaicism across Human Tissues (SMaHT) Network
The National Disease Research Interchange, in collaboration with the University of Maryland School of Medicine and Johns Hopkins All Children’s Hospital, has been awarded a research grant of $14.4M by the National Institutes of Health with a goal to transform our knowledge of how much genetic variation there is in cells and tissues throughout our bodies.
[10-May-2023] DURHAM, N.C. , May 10, 2023 /PRNewswire/ -- Young children, ages 2 to 4 years, especially those with parental history of asthma, suffered the highest rates of asthma with recurrent exacerbations (ARE) over a nearly 30-year period studied in new research funded by the Environmental influences on Child Health Outcomes Program (ECHO) at the National Institutes of Health.
National Institutes of Health Awards Grant for Pivotal Clinical Trial of gammaCore™ (nVNS) in Patients with Opioid Use Disorders
electroCore, Inc. announced that the National Institute on Drug Abuse, part of the National Institutes of Health, has awarded Emory University and the Georgia Institute of Technology a 3-year, $6.0 million grant through the NIH Helping to End Addiction Long Term Initiative to conduct a pivotal clinical trial of gammaCore for the treatment of opioid use disorder.
Akron Children's Hospital has been awarded a three-year $1.3 million grant from the National Institutes of Health /National Institute of Nursing Research to better define the practices of high-quality pediatric palliative care, particularly in seeking out the voices of the children, teens and young adults at the center of that care.
$1.67M NIH Grant Brings Scene Health’s Medication Support to Florida Pediatric Heart Transplant Centers
Children who need life-changing heart transplants in Florida will be able to receive free support to help improve medication adherence, which can potentially reduce the frequency of organ rejection over the next two years, thanks to a National Institutes of Health /National Heart Lung and Blood Institute Small Business Innovation Research award for $1.67M to Scene Health, a leading video medication adherence platform.